Publications dans lesquelles il/elle collabore avec JOAN SALLES ALVIRA (14)

2023

  1. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. A linear-polymer-based lactoferrin-selective recognition element for an ELISA mimic: A proof of concept

    Analytica Chimica Acta, Vol. 1191

  2. Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods

    Microbial Cell Factories, Vol. 21, Núm. 1

  3. Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat

    Frontiers in Neuroanatomy, Vol. 16

2021

  1. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  2. Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis

    Microchimica Acta, Vol. 188, Núm. 11

  3. Subsynaptic distribution, lipid raft targeting and g protein-dependent signalling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex

    Molecules, Vol. 26, Núm. 22

2015

  1. Nuclear diacylglycerol lipase-α in rat brain cortical neurons: Evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity

    Journal of Neurochemistry, Vol. 132, Núm. 5, pp. 489-503

2013

  1. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD

    Neuropharmacology, Vol. 64, pp. 114-123

2012

  1. Validation of an LC-ESI-MS/MS method for the quantitation of phosphodiesterase-5 inhibitors and their main metabolites in rat serum and brain tissue samples

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 70, pp. 529-533

2008

  1. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 46, Núm. 4, pp. 763-770

2007

  1. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 852, Núm. 1-2, pp. 519-528

2002

  1. Determination of methylarginines in human plasma by HPLC with pre-column derivatization using naphthalenedicarboxaldehyde as fluorogenic agent

    Journal of Separation Science, Vol. 25, Núm. 10-11, pp. 665-670

2001

  1. Determination of catecholamines and their metabolites in human plasma using liquid chromatography with coulometric multi-electrode cell-design detection

    Analytica Chimica Acta, Vol. 444, Núm. 2, pp. 211-221